Technical Analysis for PFSCF - Prometic Life Scienc

Grade Last Price % Change Price Change
grade F 5.467 -3.58% -0.2030
PFSCF closed down 3.58 percent on Friday, November 15, 2019, on 35 percent of normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical PFSCF trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -3.58%
Wide Bands Range Expansion -3.58%
Gapped Down Weakness -3.58%
Oversold Stochastic Weakness -3.58%
Older signals for PFSCF ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


ProMetic Life Sciences Inc. ( is an established biopharmaceutical company with widely recognized expertise in bioseparations, plasmaderived therapeutics and small-molecule drug development. ProMetic offers its innovative technologies for large-scale purification of biologics, drug development, proteomics and the elimination of pathogens to a growing base of industry leaders and uses its own affinity technology that provides for highly efficient extraction and purification of therapeutic proteins from human plasma in order to develop and commercialize plasma-derived therapeutics. ProMetic is also active in developing its own novel small-molecule therapeutic products targeting unmet medical needs in the fields of fibrosis, anemia, neutropenia, cancer and autoimmune diseases/inflammation as well as certain nephropathies. Headquartered in Laval (Canada), ProMetic has R&D facilities in the United Kingdom, the U.S. and Canada, manufacturing facilities in the United Kingdom and Canada and business development activities in the U.S., Europe and Asia. ProMetic's Common Shares trade on the Toronto Stock Exchange under the symbol \
Biotechnology Cancer Biopharmaceutical Life Sciences Drug Discovery Drug Development Therapeutic Products Anemia Proteomics Fibrosis Small Molecule Neutropenia Prometic Life Sciences

Is PFSCF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 549.5
52 Week Low 5.467
Average Volume 567
200-Day Moving Average 154.7664
50-Day Moving Average 12.3298
20-Day Moving Average 7.9041
10-Day Moving Average 6.3556
Average True Range 0.9395
ADX 27.98
+DI 26.3099
-DI 63.9401
Chandelier Exit (Long, 3 ATRs ) 9.6615
Chandelier Exit (Short, 3 ATRs ) 8.2855
Upper Bollinger Band 11.5398
Lower Bollinger Band 4.2684
Percent B (%b) 0.16
BandWidth 91.9953
MACD Line -2.1488
MACD Signal Line -2.3899
MACD Histogram 0.2411
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.4670
Resistance 3 (R3) 5.4670 5.4670 5.4670
Resistance 2 (R2) 5.4670 5.4670 5.4670 5.4670
Resistance 1 (R1) 5.4670 5.4670 5.4670 5.4670 5.4670
Pivot Point 5.4670 5.4670 5.4670 5.4670 5.4670
Support 1 (S1) 5.4670 5.4670 5.4670 5.4670 5.4670
Support 2 (S2) 5.4670 5.4670 5.4670 5.4670
Support 3 (S3) 5.4670 5.4670 5.4670
Support 4 (S4) 5.4670